UniProt ID | RFC3_HUMAN | |
---|---|---|
UniProt AC | P40938 | |
Protein Name | Replication factor C subunit 3 | |
Gene Name | RFC3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 356 | |
Subcellular Localization | Nucleus . | |
Protein Description | The elongation of primed DNA templates by DNA polymerase delta and epsilon requires the action of the accessory proteins proliferating cell nuclear antigen (PCNA) and activator 1.. | |
Protein Sequence | MSLWVDKYRPCSLGRLDYHKEQAAQLRNLVQCGDFPHLLVYGPSGAGKKTRIMCILRELYGVGVEKLRIEHQTITTPSKKKIEISTIASNYHLEVNPSDAGNSDRVVIQEMLKTVAQSQQLETNSQRDFKVVLLTEVDKLTKDAQHALRRTMEKYMSTCRLILCCNSTSKVIPPIRSRCLAVRVPAPSIEDICHVLSTVCKKEGLNLPSQLAHRLAEKSCRNLRKALLMCEACRVQQYPFTADQEIPETDWEVYLRETANAIVSQQTPQRLLEVRGRLYELLTHCIPPEIIMKGLLSELLHNCDGQLKGEVAQMAAYYEHRLQLGSKAIYHLEAFVAKFMALYKKFMEDGLEGMMF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSLWVDKYR ------CCCCCCCCC | 30.82 | 26552605 | |
7 | Trimethylation | -MSLWVDKYRPCSLG -CCCCCCCCCCCCCC | 33.27 | - | |
7 | Ubiquitination | -MSLWVDKYRPCSLG -CCCCCCCCCCCCCC | 33.27 | - | |
7 | Methylation | -MSLWVDKYRPCSLG -CCCCCCCCCCCCCC | 33.27 | 23644510 | |
7 | Acetylation | -MSLWVDKYRPCSLG -CCCCCCCCCCCCCC | 33.27 | 25953088 | |
8 | Phosphorylation | MSLWVDKYRPCSLGR CCCCCCCCCCCCCCC | 18.47 | 26552605 | |
12 | Phosphorylation | VDKYRPCSLGRLDYH CCCCCCCCCCCCCCC | 36.22 | 23401153 | |
20 | Acetylation | LGRLDYHKEQAAQLR CCCCCCCHHHHHHHH | 45.34 | 19608861 | |
20 | Ubiquitination | LGRLDYHKEQAAQLR CCCCCCCHHHHHHHH | 45.34 | 21906983 | |
41 | Phosphorylation | DFPHLLVYGPSGAGK CCCEEEEECCCCCCH | 24.24 | 29496907 | |
48 | Ubiquitination | YGPSGAGKKTRIMCI ECCCCCCHHHHHHHH | 50.90 | - | |
48 | Acetylation | YGPSGAGKKTRIMCI ECCCCCCHHHHHHHH | 50.90 | 26051181 | |
49 | Ubiquitination | GPSGAGKKTRIMCIL CCCCCCHHHHHHHHH | 41.96 | - | |
60 | Phosphorylation | MCILRELYGVGVEKL HHHHHHHHCCCCCEE | 12.66 | 20068231 | |
66 | Ubiquitination | LYGVGVEKLRIEHQT HHCCCCCEEEEEEEE | 40.43 | 21890473 | |
66 | 2-Hydroxyisobutyrylation | LYGVGVEKLRIEHQT HHCCCCCEEEEEEEE | 40.43 | - | |
66 | Ubiquitination | LYGVGVEKLRIEHQT HHCCCCCEEEEEEEE | 40.43 | 21890473 | |
66 | Acetylation | LYGVGVEKLRIEHQT HHCCCCCEEEEEEEE | 40.43 | 25953088 | |
73 | Phosphorylation | KLRIEHQTITTPSKK EEEEEEEEEECCCCC | 23.38 | 27732954 | |
75 | Phosphorylation | RIEHQTITTPSKKKI EEEEEEEECCCCCCE | 35.72 | 30576142 | |
76 | Phosphorylation | IEHQTITTPSKKKIE EEEEEEECCCCCCEE | 23.01 | 28985074 | |
78 | Phosphorylation | HQTITTPSKKKIEIS EEEEECCCCCCEEEE | 55.82 | 27732954 | |
79 | Acetylation | QTITTPSKKKIEIST EEEECCCCCCEEEEE | 60.33 | 25953088 | |
79 | Ubiquitination | QTITTPSKKKIEIST EEEECCCCCCEEEEE | 60.33 | - | |
91 | Phosphorylation | ISTIASNYHLEVNPS EEEECCCEEEECCHH | 12.80 | 20068231 | |
98 | Phosphorylation | YHLEVNPSDAGNSDR EEEECCHHHCCCCCH | 34.58 | 20068231 | |
111 | Sulfoxidation | DRVVIQEMLKTVAQS CHHHHHHHHHHHHHH | 2.39 | 21406390 | |
113 | Ubiquitination | VVIQEMLKTVAQSQQ HHHHHHHHHHHHHHH | 39.38 | 21906983 | |
114 | Phosphorylation | VIQEMLKTVAQSQQL HHHHHHHHHHHHHHH | 19.67 | 29083192 | |
118 | Phosphorylation | MLKTVAQSQQLETNS HHHHHHHHHHHCCCC | 15.34 | 29083192 | |
123 | Phosphorylation | AQSQQLETNSQRDFK HHHHHHCCCCCCCCE | 49.08 | - | |
125 | Phosphorylation | SQQLETNSQRDFKVV HHHHCCCCCCCCEEE | 33.73 | 17525332 | |
130 | Ubiquitination | TNSQRDFKVVLLTEV CCCCCCCEEEEEEEH | 35.40 | - | |
139 | Ubiquitination | VLLTEVDKLTKDAQH EEEEEHHHHHHHHHH | 64.33 | 21890473 | |
139 | Acetylation | VLLTEVDKLTKDAQH EEEEEHHHHHHHHHH | 64.33 | 26051181 | |
142 | Ubiquitination | TEVDKLTKDAQHALR EEHHHHHHHHHHHHH | 62.60 | - | |
154 | Ubiquitination | ALRRTMEKYMSTCRL HHHHHHHHHHCCCCE | 35.12 | - | |
154 | Acetylation | ALRRTMEKYMSTCRL HHHHHHHHHHCCCCE | 35.12 | 25953088 | |
167 | Phosphorylation | RLILCCNSTSKVIPP CEEEECCCCCCCCCC | 21.83 | 24043423 | |
168 | Phosphorylation | LILCCNSTSKVIPPI EEEECCCCCCCCCCC | 20.69 | 24043423 | |
169 | Phosphorylation | ILCCNSTSKVIPPIR EEECCCCCCCCCCCH | 25.42 | 24043423 | |
170 | Ubiquitination | LCCNSTSKVIPPIRS EECCCCCCCCCCCHH | 44.25 | - | |
197 | Phosphorylation | EDICHVLSTVCKKEG HHHHHHHHHHHHHCC | 20.08 | 22210691 | |
198 | Phosphorylation | DICHVLSTVCKKEGL HHHHHHHHHHHHCCC | 26.26 | 22210691 | |
201 | Acetylation | HVLSTVCKKEGLNLP HHHHHHHHHCCCCCC | 49.91 | 25953088 | |
201 | Ubiquitination | HVLSTVCKKEGLNLP HHHHHHHHHCCCCCC | 49.91 | - | |
202 | Ubiquitination | VLSTVCKKEGLNLPS HHHHHHHHCCCCCCH | 52.46 | 21890473 | |
202 | Ubiquitination | VLSTVCKKEGLNLPS HHHHHHHHCCCCCCH | 52.46 | 21890473 | |
209 | Phosphorylation | KEGLNLPSQLAHRLA HCCCCCCHHHHHHHH | 40.78 | 22210691 | |
218 | Ubiquitination | LAHRLAEKSCRNLRK HHHHHHHHHHHHHHH | 49.61 | - | |
225 | Ubiquitination | KSCRNLRKALLMCEA HHHHHHHHHHHHHHH | 46.69 | - | |
264 | Phosphorylation | ETANAIVSQQTPQRL HHHHHHHCCCCHHHH | 15.51 | 28555341 | |
279 | Phosphorylation | LEVRGRLYELLTHCI HHHHHHHHHHHHHCC | 11.81 | 29496907 | |
283 | Phosphorylation | GRLYELLTHCIPPEI HHHHHHHHHCCCHHH | 27.59 | 26270265 | |
308 | Ubiquitination | HNCDGQLKGEVAQMA HCCCCCCHHHHHHHH | 45.17 | - | |
343 | Phosphorylation | VAKFMALYKKFMEDG HHHHHHHHHHHHHHC | 11.55 | - | |
344 | Ubiquitination | AKFMALYKKFMEDGL HHHHHHHHHHHHHCC | 40.14 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RFC3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RFC3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RFC3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PCNA_HUMAN | PCNA | physical | 12766176 | |
CTF18_HUMAN | CHTF18 | physical | 12766176 | |
RFC4_HUMAN | RFC4 | physical | 9488738 | |
RFC1_HUMAN | RFC1 | physical | 9488738 | |
RFC4_HUMAN | RFC4 | physical | 8692848 | |
RFC1_HUMAN | RFC1 | physical | 8692848 | |
RFC4_HUMAN | RFC4 | physical | 22939629 | |
RFC5_HUMAN | RFC5 | physical | 22939629 | |
RFC2_HUMAN | RFC2 | physical | 26344197 | |
RFC4_HUMAN | RFC4 | physical | 26344197 | |
RFC5_HUMAN | RFC5 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-20, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125, AND MASSSPECTROMETRY. |